﻿<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0" xmlns:slash="http://purl.org/rss/1.0/modules/slash/">
  <channel>
    <title>James D. Bearden, III, M.D., FACP </title>
    <description> </description>
    <link>http://www.greenvillebusinessmag.com/Default.aspx?TabId=386&amp;rssauthid=68</link>
    <language>en-US</language>
    <managingEditor>do-not-reply@greenvillebusinessmag.com</managingEditor>
    <webMaster>do-not-reply@greenvillebusinessmag.com</webMaster>
    <pubDate>Thu, 17 May 2012 19:05:43 GMT</pubDate>
    <lastBuildDate>Thu, 17 May 2012 19:05:43 GMT</lastBuildDate>
    <docs>http://backend.userland.com/rss</docs>
    <generator>PackFlash Publishing RSS Generator Version 2.4.1.0</generator>
    <item>
      <title>Cancer Clinical Trials</title>
      <description>There is a reason why more than 12 million people are living today after being diagnosed with cancer. This growing number of survivors is experiencing the improvements in treatment and screening that&amp;rsquo;s been made available through research. &amp;nbsp;&lt;p&gt;&lt;a href='http://www.greenvillebusinessmag.com/View-Article/ArticleID/831/Cancer-Clinical-Trials.aspx'&gt;More...&lt;/a&gt;&lt;/p&gt;</description>
      <link>http://www.greenvillebusinessmag.com/View-Article/ArticleID/831/Cancer-Clinical-Trials.aspx</link>
      <comments>http://www.greenvillebusinessmag.com/View-Article/ArticleID/831/Cancer-Clinical-Trials.aspx</comments>
      <pubDate>Tue, 01 Nov 2011 00:00:00 GMT</pubDate>
      <slash:comments>0</slash:comments>
    </item>
  </channel>
</rss>
